Can Tenax Therapeutics, Inc. (NASDAQ:TENX) Show Upward Trend after Earnings?

20

Tenax Therapeutics, Inc. (NASDAQ:TENX) moved down -2.94% and closed its last trading session at $0.65. This Medical Sector stock currently has the Market Capitalization of 18.39 Million. The Average Volume for the stock is measured as 1.57 Million. The Stock has a 52-Week High of $2.94 and 52-Week Low of $0.42 following the dates, it touched its 52-Week High on Apr 14, 2016 and 52-Week Low on Jan 31, 2017. Currently, the Return on Assets value for the trailing twelve months is 0% with the Return on Equity and Return on Investment of 0% and 0% respectively. This firm currently has YTD (year to date) performance of -66.47 Percent which is not good. The Short Ratio for the stock is 1.32.

Tenax Therapeutics, Inc. (NASDAQ:TENX) Price to Earnings (P/E) ratio is 0. EPS or Earning per Share stands at $-0.63. The TTM operating margin is 0 percent.

Tenax Therapeutics, Inc. (NASDAQ:TENX) reports its Earnings on Tue 21 Mar (In 2 Days). The estimated EPS for the current quarter is said to be $-0.14. Following Earnings result, share price were UP 2 times out of last 5 Qtrs. The stock has reduced about -56.4% since it reported its last earnings. The Closing price of Tenax Therapeutics, Inc. (NASDAQ:TENX) at Last Earnings was $1.49 as compared to the previous closing price of $0.67. The Predicted Move on the 7th day after Tenax Therapeutics, Inc. (NASDAQ:TENX) will release its earnings at about 6%.

By Looking at Earnings History, Out of 12 Quarters when the Earnings were reported, Tenax Therapeutics, Inc. (NASDAQ:TENX) beats earnings by 8%, The Stock Missed EarningsĀ  1 times and has met earningsĀ  1 times.

Earnings History:

We will discuss the past Quarters Earnings below:

Tenax Therapeutics, Inc. (NASDAQ:TENX) reported its previous quarter on 11/10/2016 where it reported the Actual Earnings of $0.13. The Closing price before the company posted its earnings was $1.49. The Stock surged on the very next day of earnings and maintained its stock price at $1.57 by showing a % change of 5.37 percent from its previous closing price. The Next Day Volume after Earnings was reported as 54137. On the 7th day After Earnings Report, the stock hit its share price as $1.38 by showing -7.38% decrease from the Stock price Before Earnings were reported.

On 08/09/2016, the stock reported the EPS of $-0.15 where Analysts were projecting the EPS to be $-0.17 showing a difference of $0.02. Thus Surprise Factor was there with 11.8 percent. Before Earnings Announcement on 08/09/2016, the firm had its stock price of $2.48. And immediately on the next day after earnings announcement, the stock declined 0% and closed its trading session at $2.48. On 7th Day after earnings release, Tenax Therapeutics, Inc. (NASDAQ:TENX) dropped to -3.23% from $2.48 to $2.4.

Company Profile:

Tenax Therapeutics, Inc., a specialty pharmaceutical company, focused on the development and commercialization of a portfolio of products for the critical care market in the United States and Canada. It focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing Low Cardiac Output Syndrome. The company offers Wundecyte, a wound-healing gel. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.